Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jorge Braier"'
Autor:
Egle Kvedaraite, Paul Milne, Ahad Khalilnezhad, Marion Chevrier, Raman Sethi, Hong Kai Lee, Daniel W. Hagey, Tatiana von Bahr Greenwood, Natalia Mouratidou, Martin Jädersten, Nicole Yee Shin Lee, Lara Minnerup, Yingrou Tan, Charles-Antoine Dutertre, Nathan Benac, You Yi Hwang, Josephine Lum, Amos Hong Pheng Loh, Jessica Jansson, Karen Wei Weng Teng, Shabnam Khalilnezhad, Weili Xu, Anastasia Resteu, Hong Liang Tey, Ng Lai Guan, Anis Larbi, Shanshan Wu Howland, Henrik Arnell, Samir E. L. Andaloussi, Jorge Braier, Georgios Rassidakis, Laura Galluzzo, Andrzej Dzionek, Jan-Inge Henter, Jinmiao Chen, Matthew Collin, Florent Ginhoux
Publikováno v:
Science Immunology. 7
Langerhans cell histiocytosis (LCH) is a potentially fatal neoplasm characterized by the aberrant differentiation of mononuclear phagocytes, driven by mitogen-activated protein kinase (MAPK) pathway activation. LCH cells may trigger destructive patho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::153d94f7311e59557ee700e7a07f967f
https://doi.org/10.1126/sciimmunol.add3330
https://doi.org/10.1126/sciimmunol.add3330
Autor:
María Marta Buján, Cristian Sánchez La Rosa, María Laura Galluzzo Mutti, Jorge Braier, Eli L. Diamond
Publikováno v:
Pediatr Dermatol
Progressive nodular histiocytosis is a rare variant of non-Langerhans cell histiocytosis that affects the skin and mucous membranes and displays a progressive clinical course and poor response to treatment. We describe a case of severe progressive no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5488adadd954976c1b9f9851fa0bfc6b
https://europepmc.org/articles/PMC8819602/
https://europepmc.org/articles/PMC8819602/
Autor:
Nagore G. Olaciregui, Guillermo Chantada, Nicolas Pinto, Guido Felizzia, Noelia Salvador Marcos, Estefania Rossetti, Veronica Celis Passini, Cinzia Lavarino, Jorge Braier, Laura Galluzzo, Xiomara Carrere
Publikováno v:
Pediatric Blood & Cancer. 68
Targeted therapies with MAPK inhibitors have proven to modulate the clinical manifestations of patients with Langerhans cell histiocytosis (LCH). We explored the presence of BRAFV600E mutation in our cohort of patients with LCH and cholestasis, scler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f09fa0579f399e675b52f16e60bbe179
https://doi.org/10.1002/pbc.29115
https://doi.org/10.1002/pbc.29115
Autor:
Xiomara, Carrere, Nicolas, Pinto, Nagore, Gene Olaciregui, Laura, Galluzzo, Estefania, Rossetti, Veronica, Celis Passini, Noelia, Salvador Marcos, Guillermo, Chantada, Jorge, Braier, Cinzia, Lavarino, Guido, Felizzia
Publikováno v:
Pediatric bloodcancerREFERENCES. 68(7)
Targeted therapies with MAPK inhibitors have proven to modulate the clinical manifestations of patients with Langerhans cell histiocytosis (LCH). We explored the presence of BRAF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1f20427b50c594cbcebbdf7a574b3741
https://pubmed.ncbi.nlm.nih.gov/33991404
https://pubmed.ncbi.nlm.nih.gov/33991404
Publikováno v:
Hormone research in paediatrics. 94(1-2)
Langerhans cell histiocytosis (LCH) is a disorder of the mononuclear phagocyte system that can affect almost any organ and system. The most common central nervous system (CNS) manifestation in LCH is the infiltration of the hypothalamic-pituitary reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31ff906f25ac5b8648f7603321f77add
https://pubmed.ncbi.nlm.nih.gov/34167121
https://pubmed.ncbi.nlm.nih.gov/34167121
Autor:
Milen Minkov, Ulrike Pötschger, Nirav Thacker, Itziar Astigarraga, Jorge Braier, Jean Donadieu, Jan-Inge Henter, Thomas Lehrnbecher, Carlos Rodriguez-Galindo, Elena Sieni, Vasanta Nanduri, Cor van den Bos, Oussama Abla, M. Aricò, H. Gadner, N. Grois, G. Janka-Schaub, S. Ladisch, K. McClain, S. Weitzman, K. Windebank
Publikováno v:
The Journal of Pediatrics. 237:65-70.e3
OBJECTIVE To evaluate the prognostic impact of gastrointestinal involvement on the survival of children with Langerhans cell histiocytosis (GI-LCH) registered with the international clinical trials of the Histiocyte Society. STUDY DESIGN This was a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ace55c1371bbad0c43d673beb633da7
https://doi.org/10.1016/j.jpeds.2021.06.016
https://doi.org/10.1016/j.jpeds.2021.06.016
Autor:
Jorge Braier, Pedro Zubizarreta, Alicia Belgorosky, Lina Margarita Vega, Carmen Malossetti, Elisa Vaiani
Publikováno v:
Hormone Research in Paediatrics. 87:51-57
Background: Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder of unknown etiopathogenesis. Central diabetes insipidus (CDI) is the most frequent endocrine manifestation and is a known risk factor for the development of further anteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f23ed46904dba683c69e42fbd776fe57
https://doi.org/10.1159/000452996
https://doi.org/10.1159/000452996
Autor:
Jean Donadieu, Eric D. Jacobsen, Carlos Rodriguez-Galindo, Oussama Abla, Zdenka Krenova, Sheila Weitzman, Ronald Jaffe, Benjamin H. Durham, Jean-François Emile, Fleur Cohen-Aubart, Kenneth L. McClain, Julien Haroche, James A. Whitlock, Carl E. Allen, Jorge Braier, Jennifer Picarsic, Frédéric Charlotte, Eli L. Diamond
Publikováno v:
Blood. 131(26)
Rosai-Dorfman-Destombes disease (RDD) is a rare non–Langerhans cell histiocytosis characterized by accumulation of activated histiocytes within affected tissues. RDD, which now belongs to the R group of the 2016 revised histiocytosis classification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6811cca67844bbe6ef5b976fc9b238ee
https://pubmed.ncbi.nlm.nih.gov/29720485
https://pubmed.ncbi.nlm.nih.gov/29720485
Autor:
Daniel Pollono, Jorge Braier, Guadalupe Rey, Antonio Latella, Pedro Zubizarreta, Eduardo Lagomarsino, Diego Rosso
Publikováno v:
Journal of Pediatric Hematology/Oncology. 36:e280-e284
This study evaluated the outcome of patients with symptomatic bone Langerhans cell histiocytosis (LCH) treated with indomethacin alone, either at diagnosis or after reactivation (after recurrence with previous therapies). We evaluated the nonrandomiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c664774e445c4b437eab567b238f0f1b
https://doi.org/10.1097/mph.0000000000000165001
https://doi.org/10.1097/mph.0000000000000165001
Autor:
Jorge, Braier
Publikováno v:
Pediatric bloodcancer. 64(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6c9375680cb06aaf7785271a40848a09
https://pubmed.ncbi.nlm.nih.gov/27314817
https://pubmed.ncbi.nlm.nih.gov/27314817